In the Quest for a Cure for Type 1 Diabetes, Two Companies Merge In the Quest for a Cure for Type 1 Diabetes, Two Companies Merge

Vertex Pharmaceuticals ’ acquisition of ViaCyte raises hopes for faster development of stem cell-derived islet transplantation therapy.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Diabetes & Endocrinology News Source Type: news